enoximone has been researched along with Cardiac Failure in 175 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 81 (46.29) | 18.7374 |
1990's | 78 (44.57) | 18.2507 |
2000's | 13 (7.43) | 29.6817 |
2010's | 3 (1.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bobowski, G; Bristol, JA; Burke, SE; Evans, DB; Newton, RS; Sircar, I; Steffen, RP; Weishaar, RE | 1 |
Bobowski, G; Bristol, JA; Duell, BL; Evans, DB; Sircar, I | 1 |
Erhardt, PW | 1 |
Bristol, JA; Evans, DB; Moos, WH; Sircar, I; Weishaar, RE | 1 |
B Bastos, M; Brugts, JJ; Bunge, JJH; Constantinescu, AA; Daemen, J; den Uil, CA; Engstrom, AE; Jewbali, LS; Lenzen, MJ; Manintveld, OC; Van Mieghem, NM; Wilschut, JM; Zijlstra, F | 1 |
Balk, AH; Caliskan, K; Constantinescu, AA; Jewbali, L; Manintveld, OC; van Domburg, R | 1 |
Bartsota, M; Bentley, S; Furck, AK; Rigby, ML; Slavik, Z | 1 |
Abraham, WT; Böhm, M; Bristow, MR; Corbalan, R; De Marco, T; DeMets, D; Eichhorn, E; Elkayam, U; Gerber, M; Komajda, M; Linseman, J; Liu, P; Mareev, V; Metra, M; Perrone, SV; Poole-Wilson, P; Roecker, E; Stewart, J; Swedberg, K; Tendera, M; Wiens, B | 1 |
Cohn, JN | 1 |
Bristow, MR; D'Aloia, A; Dei Cas, L; Metra, M; Muneretto, C; Nodari, S; Robertson, AD | 1 |
Akintürk, H; Benson, M; Bräu, M; Hempelmann, G; Junger, A; Kwapisz, MM; Müller, M; Schindler, E | 1 |
Campana, C; Constantin, C; Fontana, A; Ghio, S; Klersy, C; Raineri, C; Tavazzi, L | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Ingle, L; Lalukota, K | 1 |
Hausmann, H; Hennig, F; Hetzer, R; Lehmkuhl, HB; Potapov, EV; Sodian, R; Volk, HD; Wagner, FD | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Lammiman, M; Loh, H; Nasir, M; Witte, KK | 1 |
Francis, GS; Tang, WH | 1 |
Bristow, MR; Demets, DL; Eichhorn, E; Evans, G; Feldman, AM; Freytag, JW; Gerber, MJ; Gorczynski, R; Hartman, C; Liard, JF; Linseman, JV; Lowes, BD; Metra, M; Robertson, AD; Roecker, EB; Shakar, SF; Stewart, J | 1 |
Abraham, WT; Boehmer, JP; Bristow, MR; Carson, PE; Eichhorn, E; Feldman, AM; Gerber, MJ; Gilbert, EM; Kao, A; Krueger, SK; Leier, CV; Lowes, BD; Mathier, MA; McGrew, FA; Metra, M; Oren, RM; Robertson, AD; Shakar, SF; White, BG; Wold, GE; Zisman, LS | 1 |
Asif, H; Chaudhari, MP; Crossland, DS; Kirk, RC; O'Sullivan, JJ; Roche, SL | 1 |
Carlier, J; D'Orio, V; el Allaf, D | 1 |
Follansbee, WP; Generalovich, T; Reddy, PS; Spangenberg, RB; Uretsky, BF | 1 |
Crawford, MH; Kennedy, GT; Richards, KL; Sodums, MT | 1 |
Generalovich, T; Lang, JF; Okerholm, RA; Reddy, PS; Salerni, R; Spangenberg, RB; Uretsky, BF; Valdes, AM | 1 |
Hirshfeld, JW; Janicki, JS; Laskey, WK; Likoff, MJ; Martin, JL; Weber, KT | 1 |
Atherton, B; Chatterjee, K; Curran, D; Kereiakes, A; Kereiakes, D; Parmley, WW; Spangenberg, R | 1 |
Botvinick, EH; Buckingham, M; Chatterjee, K; Kereiakes, DJ; Lanzer, P; Parmley, WW; Spangenberg, R; Viquerat, C | 1 |
Amin, DK; Hulse, S; Shah, PK; Shellock, FG; Swan, HJ | 1 |
Bristow, MR | 1 |
Harwood, R | 1 |
Barbato, G; Bracchetti, D; Cantelli, I; Casella, G; Pavesi, PC | 1 |
Cowley, AJ; Skene, AM | 1 |
Goullon, A; Ries, D | 1 |
Arnal, JF; Bourdarias, JP; Chikli, F; Delorme, G; Dubourg, O; Dumas, C; Jondeau, G; Kamoun, L | 1 |
Hasenfuss, G; Holubarsch, C; Just, H; Pieske, B | 1 |
Mitrovic, V; Neuzner, J; Opper, H; Schlepper, M; Thormann, J | 1 |
Braun, P; Fieten-Rumswinkel, M; Heinrich, KW; Heinzler, R; Hetzer, R; May, E; Park, JW; Wirtz, JH | 1 |
Günnicker, M; Marggraf, G; Reidemeister, JC; Zerkowski, HR | 1 |
Hachenberg, T | 1 |
Jähnchen, E; Trenk, D | 1 |
Branzi, A; Caldarera, I; Galie, N; Grattoni, C; Magnani, B; Magnani, G; Melandri, G; Rapezzi, C | 1 |
Candito, M; Dadoun-Dybal, M; Gibelin, P; Morand, P; Robillon, JF | 1 |
Braun, P; Heinrich, KW; Heinzler, R; Hetzer, R; Kang, CS; May, E; Mertens, S; Park, JW; Wirtz, JH | 1 |
Benvenuti, C; Cachera, JP; Deleuze, PH; el Sayed, A; Houel, R; Loisance, DY; Mazzucotelli, JP; Saal, JP; Tarral, A | 1 |
Cocca-Spofford, D; Dec, GW; Fifer, MA; Herrmann, HC; Semigran, MJ | 1 |
Annane, D; Auzepy, P; Bellissant, E; Giudicelli, JF; Richard, C; Teboul, JL; Thuillez, C | 1 |
Caldicott, LD; Channer, KS; Hawley, K; Heppell, R; Woodmansey, PA | 1 |
Bristow, MR; Eki, Y; Focaccio, A; Krall, J; Movsesian, M; Peeters, G; Roden, R | 1 |
Lindner, W; Merkenschlager, A; Mühlbauer, S; Nicolai, T; Obermaier-Kusser, B; Paetzke, J; Reiter, K; Roscher, A; Timnik, A | 1 |
Abraham, WT; Bristow, MR; Ferguson, DA; Gilbert, EM; Lowes, BD; Robertson, AD; Shakar, SF; Zisman, LS | 1 |
Chatterjee, K; De Marco, T | 1 |
Mitrovic, V; Schönburg, M; Schulz, O; Thormann, J | 1 |
Bristow, MR; Dec, GW; DeWood, MA; Gorczynski, RJ; Greenberg, MA; Higginbotham, M; LeJemtel, TH; Lowes, BD; Petrovich, L; Rahko, PS; Robertson, AD; Roden, RL; Schleman, MM | 1 |
England, PJ; Murray, KJ | 1 |
Esumi, K; Sudo, Y; Takai, M | 1 |
Berré, J; Kahn, RJ; Léon, M; Mélot, C; Vincent, JL | 2 |
Arnal, JF; Beauchet, A; Bock, F; Bourdarias, JP; Brun, D; Delorme, G; Dinanian, S; Dubourg, O; Hardy, A; Jondeau, G | 1 |
Thormann, J | 1 |
Annane, D; Bellissant, E; Depret, J; Richard, C; Teboul, JL; Thuillez, C | 1 |
Gilbert, EM; Hershberger, RE; Lee, HR; Mealey, PC; Menlove, R; O'Connell, JB; Port, JD; Rasmussen, R; Renlund, DG; Volkman, K | 1 |
Dieterich, HA; Schmitz, W; Scholz, H | 1 |
Lissmann, H; Mitrovic, V; Neuzner, J; Pitschner, HF; Schlepper, M | 1 |
Dieterich, HA; Huber, R; Klauss, V; Mudra, H; Scheininger, M; Schmidt, R; Theisen, K; Tschaidse, O; Vogler, A; Zwehl, W | 1 |
Brogden, RN; Heel, RC; Vernon, MW | 1 |
Narahara, KA | 1 |
World, MJ | 1 |
Hasenfuss, G; Holubarsch, C; Just, H; Thierfelder, L | 1 |
Doi, M; Itoh, H; Koike, A; Sakuma, A; Taniguchi, K | 1 |
Coghlan, JG; Ilsley, CD; Mitchell, AG; Norell, M | 1 |
Bekele, T; Kates, RE; Lebsack, C; Mead, RH; Okerholm, RA; Rubin, GM; Ruder, MA; Smith, NA; Winkle, RA | 1 |
Kates, RE; Lebsack, C; Mead, RH; Ruder, MA; Smith, N; Winkle, RA | 1 |
Friedel, N; Hetzer, R; Lemme, A; Schüler, S; Teebken, M | 1 |
Hasenfuss, G; Heiss, HW; Holubarsch, C; Just, H; Thierfelder, L | 1 |
Boldt, J; Hempelmann, G | 1 |
Birnbaum, DE; Dieterich, HA; Gieseke, R; Jähnchen, E; Kasper-König, W; Preuner, JG; Trenk, D | 1 |
Zeplin, HE | 1 |
Peters, P; Saborowski, F; Schneider, M | 1 |
Bussmann, WD; Dieterich, HA; Kaltenbach, M; Kneissl, GD; Scholz, M | 1 |
Demeyere, R; Flameng, W; Isringhaus, H; Lunkenheimer, PP; Redmann, K; Rettig, G | 1 |
Erbel, R; Meyer, J; Rhein, S; Treese, N; Werneyer, A | 1 |
Dieterich, HA; Gilfrich, HJ | 1 |
Brichant, C; Cauwe, F; De Coster, P; Gonzalez, M; Installe, E; Lessire, H | 1 |
Hasenfuss, G; Holubarsch, CH; Just, HJ; Thierfelder, L | 1 |
Betschart, AR; Kolesar, JA; Murali, S; Reddy, PS; Tokarczyk, TR; Uretsky, BF | 1 |
Dieterich, HA; Glauner, T; Hertrich, F; Jähnchen, E; Trenk, D; Winkelmann, B | 1 |
Swan, HJ | 1 |
Benotti, J; Dec, GW; Herrmann, HC; Jessup, M; Konstam, MA; Leier, CV; Murali, S; Sandberg, JA; Uretsky, BF | 1 |
Bekele, T; Kates, RE; Lebsack, C; Mead, RH; Okerholm, R; Rubin, J; Ruder, MA; Smith, NA; Winkle, RA | 1 |
Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois Randé, JL; Loisance, D | 1 |
Baligadoo, SJ; Maiti, D; Manraz, M; Murday, M; Subratty, H; Tarral, A | 1 |
Cowley, AJ; Fullwood, L; Hampton, JR; Muller, AF; Stainer, K | 1 |
Beauchet, A; Bourdarias, JP; Delorme, G; Dubourg, O; Hardy, A; Tarral, A | 1 |
Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois-Randé, JL; Duval-Moulin, AM; Lellouche, D; Loisance, D; Merlet, P; Saal, JP | 1 |
Brochier, M | 1 |
Achard, F; Benacerraf, A; Bock, F; Bouchoucha, H; de Langenhagen, B; Hennetier, G; Scholl, JM | 1 |
Annane, D; Bellissant, E; Richard, C; Teboul, JL; Thuillez, C | 1 |
Bounhoure, JP; Edouard, P; Fauvel, JM; Fourcade, J; Galinier, M; Massabuau, P; Puel, J; Rochiccioli, JP | 1 |
Besse, P; Coste, P; Durrieu, C; Le Goff, G; Rochoux, G | 1 |
Garraffo, R; Gibelin, P; Lapalus, P; Morand, P; Sbirrazzuoli, V | 1 |
Albo, C; Baron, JF; Coriat, P; Souguir, S; Viars, P | 1 |
Allal, J; Barraine, R; Bouton, S; Couetil, JP; Dreyfus, G; Farge, D; Ourbak, P; Pornin, M; Prevost, D; Sarkis, A | 1 |
Dage, RC; Okerholm, RA | 1 |
Braunwald, E; Colucci, WS; Wright, RF | 1 |
Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH | 1 |
Crawford, MH; Ferry, DR; Kennedy, GT; O'Rourke, RA | 1 |
Anand, IS; Lipkin, DP; Poole-Wilson, PA; Scriven, AJ; Sutton, GC | 2 |
Erbel, R; Meyer, J; Pop, T; Rhein, S; Treese, N; von Olshausen, K; Werneyer, A | 1 |
Geibel, A; Hohnloser, SH; Just, H; Meinertz, T; Zehender, M | 1 |
Husseini, H; Mitrovic, V; Neuzner, J; Schlepper, M; Volz, M | 1 |
Dieterich, HA; Fehske, W; Peters, P; Saborowski, F; Schneider, M | 1 |
Gilfrich, HJ; Römer, A; Witzke-Gross, J | 1 |
Erbel, R; Meyer, J; Rhein, S; Treese, N | 1 |
Baim, DS | 2 |
Hood, WB | 1 |
Bekele, T; Clifton, G; McMahon, G; Ryan, J; Vargas, R; Wallin, D | 1 |
Heger, JJ; Klein, LS; Miles, WM; Minardo, JD; Prystowsky, EN; Zipes, DP | 1 |
Hess, ML; Wood, MA | 1 |
Binkley, PF; Huss-Randolph, P; Leier, CV; Starling, RC | 1 |
Binet, JP; Bock, F; Duffet, JP; Horon, A; Nottin, R; Planche, C; Touchot, A | 1 |
Erbel, R; Henrichs, KJ; Meyer, J; Rhein, S; Treese, N | 1 |
Cowley, AJ; Hampton, JR; Rowley, JM; Stainer, K; Wynne, RD | 1 |
Binkley, PF; Leier, CV; Ryan, JM; Shaffer, PB | 1 |
Kahn, RJ; Madhoun, P; Primo, G; Vincent, JL | 1 |
Janicki, JS; Maskin, CS; Weber, KT | 2 |
Andersson, KE | 1 |
Dhainaut, JF | 1 |
Reddy, PS; Uretsky, BF; Valdes, AM | 1 |
Goto, T; Nunoki, K; Satoh, K; Taira, N | 1 |
Hakki, A; Iskandrian, AS; Likoff, MJ; Ulrich, S | 1 |
Generalovich, T; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 2 |
Cremer, GM; Haegele, KD; Meyer, J; Pop, T; Treese, N | 1 |
Jain, MC; Janicki, JS; Weber, KT | 1 |
Uretsky, BF | 1 |
Leier, CV | 1 |
Boucher, CA; Dec, GW; Fifer, MA; Herrmann, HC; Ruddy, TD; Strauss, HW | 1 |
Boucher, CA; Fifer, MA; Herrmann, HC; Ruddy, TD; Strauss, HW; William, G | 1 |
Chatterjee, K; Daly, PA; Kereiakes, D; Modin, G; Simonton, CA | 1 |
Alken, RG; Diefenbach, C; Erbel, R; Meyer, J; Mohr-Kahaly, S; Rhein, S; Treese, N | 1 |
Janicki, JS; Shroff, SG; Weber, KT | 1 |
Chan, KY; Lang, JF; Okerholm, RA; Ruberg, SJ; Thompson, GA | 1 |
Barbieri, A; Bourdarias, JP; Delorme, G; Diefenbach, C; Erbel, R; Installe, E; Lellouche, D; Mattioli, G; Meyer, J; Vernant, P | 1 |
Leier, CV; Matthews, S; Meiler, SE; Unverferth, DV | 1 |
Chatterjee, K; Kereiakes, D; Podolin, R; Viquerat, C | 1 |
Crawford, MH | 1 |
Collard, P; Gonzalez, M; Installé, E; Jacquemart, JL; Pourbaix, S; Roulette, F; Tremouroux, J | 1 |
Bristow, MR; Gilbert, EM; Mason, JW | 1 |
Butzer, F; Dieterich, HA; Heinrich, F; Zipperle, G | 1 |
Belhadj, K; Brunotte, F; Gilgenkrantz, JM; Iannascoli, F; Juilliere, Y; Khalife, K; Zannad, F | 1 |
Helfer, D; Jessup, M; Samaha, J; Ulrich, S | 1 |
Choraria, S; Dieterich, HA; Erbel, R; Meyer, J; Pilcher, J; Rhein, S; Treese, N | 1 |
Choraria, SK; Pilcher, J; Taylor, D | 1 |
Holtz, L; Leier, CV; Lima, JJ; MacKichan, JJ; Shields, BJ; Sterechele, J | 1 |
Beato, E; Berardi, C; Branzi, A; Ferretti, RM; Magnani, B; Magnani, G; Melandri, G; Zannoli, R | 1 |
Leier, CV; Lima, JJ; Meiler, SE; Unverferth, DV | 1 |
Bourdarias, JP; Delorme, G; Dubois-Randé, JL; Duval, AM; Lellouche, D; Merlet, P; Tarral, A; Vernant, P | 1 |
Bernard, R; Dereppe, H; Henuzet, C; Renard, M; Stevens, E | 1 |
Tommaso, CL | 1 |
Amin, DK; Hulse, S; Shah, PK; Shellock, F; Swan, HJ | 1 |
Amin, DK; Brandon, G; Hulse, S; Shah, PK; Shellock, FG; Spangenberg, R; Swan, HJ | 1 |
Chatterjee, K; Daly, PA; Frank, P; Kereiakes, D; Morris, DL; Parmley, WW; Viquerat, CE; Wexman, M | 1 |
Generalovich, T; Reddy, PS; Uretsky, BF; Valdes, A; Verbalis, JG | 1 |
Amin, DK; Hulse, S; Shah, PK; Shellock, F | 1 |
Rubin, SA; Tabak, L | 1 |
Grose, R; LeJemtel, TH; Maskin, CS; Strain, J | 1 |
22 review(s) available for enoximone and Cardiac Failure
Article | Year |
---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cardiotonic Agents; Cardiovascular Agents; Crataegus; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Homozygote; Humans; Oxygen Consumption; Plant Extracts; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1; Societies, Medical; Stroke Volume; Survival Analysis; Treatment Failure; Treatment Outcome; United States | 2004 |
Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE.
Topics: Cardiac Pacing, Artificial; Cardiology; Congresses as Topic; Defibrillators, Implantable; Enalapril; Enoximone; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Isoxazoles; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Societies, Medical; Survival Analysis; Thiophenes; Treatment Outcome | 2005 |
The year in heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Pacing, Artificial; Cardiography, Impedance; Cardiomyopathy, Dilated; Chronic Disease; Clinical Trials as Topic; Comorbidity; Disease Management; Enoximone; Heart Failure; Hemodynamics; Humans; Kidney Diseases; Natriuretic Peptide, Brain; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase; Pacemaker, Artificial; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Xanthine Oxidase | 2005 |
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
Use of oral enoximone in pharmacologic bridging to cardiac transplantation.
Topics: Administration, Oral; Clinical Trials as Topic; Dose-Response Relationship, Drug; Enoximone; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Palliative Care; Postoperative Complications; Survival Rate; Treatment Outcome | 1994 |
[Clinico-pharmacologic aspects of therapy with enoximone].
Topics: Dose-Response Relationship, Drug; Drug Interactions; Enoximone; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Myocardial Contraction | 1994 |
Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Benzimidazoles; Dihydropyridines; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoenzymes; Milrinone; Oxindoles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Vasodilator Agents | 1992 |
[Mechanism of the positive inotropic effect of phosphodiesterase inhibitors].
Topics: Cardiotonic Agents; Coronary Circulation; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Postoperative Complications; Ventricular Function, Left | 1991 |
Enoximone. A review of its pharmacological properties and therapeutic potential.
Topics: Animals; Cardiotonic Agents; Clinical Trials as Topic; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles | 1991 |
[Tolerance of enoximone in patients with heart failure].
Topics: Cardiotonic Agents; Drug Interactions; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1991 |
[Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardial Contraction; Vasodilation | 1990 |
Pharmacology and pharmacokinetics of enoximone.
Topics: Animals; Cardiotonic Agents; Dogs; Enoximone; Heart Failure; Humans; Imidazoles; Structure-Activity Relationship; Vasodilator Agents | 1990 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone | 1986 |
The role of novel inotropic agents in the treatment of heart failure.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors | 1986 |
Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine.
Topics: Clinical Trials as Topic; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
Long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors.
Topics: Administration, Oral; Amrinone; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
Effects of new inotropic agents on exercise performance.
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Chronic Disease; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Muscles; Oxygen; Oxygen Consumption; Physical Exertion; Pulmonary Wedge Pressure; Pyridones; Time Factors | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
Enoximone.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1988 |
Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Topics: Administration, Oral; Animals; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Dogs; Enoximone; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Imidazoles; Injections, Intravenous; Kinetics; Lactates; Myocardial Contraction; Time Factors; Vasodilation | 1986 |
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Physical Exertion; Pyridones; Thrombocytopenia; Time Factors | 1986 |
54 trial(s) available for enoximone and Cardiac Failure
Article | Year |
---|---|
Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Treatment Outcome | 2019 |
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiotonic Agents; Chronic Disease; Double-Blind Method; Enoximone; Exercise; Exercise Tolerance; Heart Failure; Heart Rate; Hospitalization; Humans; Kaplan-Meier Estimate; Middle Aged; Young Adult | 2009 |
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Angiography; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Chronic Disease; Dobutamine; Echocardiography; Enoximone; Exercise Test; Female; Heart Failure; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
Topics: Administration, Oral; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enoximone; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Retrospective Studies; Survival Rate; Treatment Outcome; United States; Ventricular Function, Left | 2007 |
The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1983 |
Comparative hemodynamic effects of intravenous digoxin and enoximone in severe chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Cross-Over Studies; Digoxin; Enoximone; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Severity of Illness Index; Ventricular Function, Left | 1994 |
Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.
Topics: Aged; Double-Blind Method; Drug Administration Schedule; Enoximone; Female; Follow-Up Studies; Heart Failure; Humans; Male; Quality of Life | 1994 |
Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
Topics: Administration, Oral; Aged; Cardiac Output, Low; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged | 1994 |
[Concept for therapy of heart failure in heart surgery].
Topics: Amrinone; Cardiac Output, Low; Enoximone; Heart Diseases; Heart Failure; Heart Rate; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Intraoperative Complications; Myocardial Contraction; Postoperative Complications; Prospective Studies; Single-Blind Method | 1994 |
Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 1993 |
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 1998 |
Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials, Phase II as Topic; Double-Blind Method; Electrocardiography, Ambulatory; Enoximone; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors | 2000 |
Addition of enoximone to adrenergic agents in the management of severe heart failure.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiotonic Agents; Drug Evaluation; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Postoperative Care; Prospective Studies; Sympathomimetics | 1992 |
[Double-blind clinical and echocardiographic study of oral enoximone versus placebo in severe cardiac insufficiency].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Double-Blind Method; Echocardiography, Doppler; Electrocardiography, Ambulatory; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Placebos; Prospective Studies | 1992 |
Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group.
Topics: Administration, Oral; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Enoximone; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors | 1991 |
Effects of enoximone on exercise tolerance in patients with mild to moderate heart failure.
Topics: Aged; Anaerobic Threshold; Carbon Dioxide; Cardiotonic Agents; Enoximone; Exercise Test; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption | 1991 |
Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.
Topics: Aged; Dose-Response Relationship, Drug; Drug Evaluation; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Phosphodiesterase Inhibitors | 1991 |
Disposition kinetics of orally administered enoximone in patients with moderate to severe heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Enoximone; Female; Half-Life; Heart Failure; Humans; Imidazoles; Male; Metabolic Clearance Rate; Middle Aged; Time Factors | 1991 |
[Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Drug Therapy, Combination; Enoximone; Epinephrine; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusion Pumps; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications | 1991 |
[Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Dopamine; Enoximone; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications | 1991 |
[The effect of enoximone and catecholamines on renal function after open heart surgery].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Diuresis; Dobutamine; Enoximone; Heart Failure; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Imidazoles; Kidney Function Tests; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications; Prospective Studies; Vascular Resistance | 1991 |
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Topics: Aged; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors | 1991 |
[Acute effect of enoximone and captopril in patients with heart failure].
Topics: Adult; Captopril; Cardiac Output; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure | 1991 |
[Enoximone and ventricular arrhythmia in chronic heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Cardiotonic Agents; Electrocardiography, Ambulatory; Enoximone; Heart Failure; Heart Ventricles; Humans; Imidazoles; Phosphodiesterase Inhibitors; Risk Factors | 1991 |
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.
Topics: Administration, Oral; Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles; Multicenter Studies as Topic; Oxygen Consumption; Placebos; Severity of Illness Index; Survival Analysis | 1990 |
Pharmacodynamics of enoximone during intravenous infusion.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Kidney | 1990 |
Effects of enoximone on quality of life.
Topics: Cardiotonic Agents; Drug Evaluation; Dyspnea; Enoximone; Fatigue; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors; Physical Exertion; Quality of Life | 1990 |
Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics.
Topics: Aged; Captopril; Diuretics; Enoximone; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors | 1990 |
Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Drug Evaluation; Echocardiography; Echocardiography, Doppler; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Quality of Life | 1990 |
[Enoximone: hemodynamic effect in patients with cardiac insufficiency].
Topics: Adult; Aged; Cardiotonic Agents; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Injections, Jet; Male; Middle Aged | 1990 |
[Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1990 |
[Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
Topics: Adult; Aged; Angiography, Digital Subtraction; Cardiomyopathy, Dilated; Cardiotonic Agents; Cineangiography; Dobutamine; Enoximone; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Vasodilation | 1990 |
[Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
Topics: Aged; Cardiotonic Agents; Chronic Disease; Drug Evaluation; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Injections, Jet; Middle Aged | 1990 |
[Enoximone in the hemodynamic evaluation before heart transplantation. A new test].
Topics: Adult; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside | 1990 |
Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
Topics: Aged; Captopril; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Random Allocation | 1988 |
Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine.
Topics: Clinical Trials as Topic; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy.
Topics: Adult; Aged; Clinical Trials as Topic; Digitalis; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enoximone; Exercise Test; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Plants, Medicinal; Plants, Toxic; Random Allocation | 1989 |
Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study.
Topics: Adult; Aged; Captopril; Double-Blind Method; Enoximone; Exercise Test; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Pulmonary Gas Exchange; Random Allocation; Vascular Resistance | 1989 |
Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure.
Topics: Blood Pressure; Cardiotonic Agents; Clinical Trials as Topic; Diastole; Echocardiography; Enoximone; Heart Failure; Humans; Imidazoles; Myocardial Contraction; Phosphodiesterase Inhibitors; Radionuclide Imaging; Random Allocation | 1989 |
A dose-response study of intravenous enoximone in congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1987 |
A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Vascular Resistance | 1987 |
Intravenous use of enoximone.
Topics: Adolescent; Adult; Aged; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Enoximone; Female; Heart Failure; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1987 |
Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Topics: Aged; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside | 1987 |
Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
Topics: Administration, Oral; Adolescent; Cardiotonic Agents; Clinical Trials as Topic; Enoximone; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Random Allocation | 1987 |
A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
Topics: Administration, Oral; Aged; Captopril; Cardiotonic Agents; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Random Allocation; Time Factors | 1987 |
A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Random Allocation | 1987 |
Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Clinical Trials as Topic; Double-Blind Method; Enoximone; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Random Allocation | 1987 |
Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience.
Topics: Adult; Capsules; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Echocardiography; Enoximone; Exercise Test; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Long-Term Care; Middle Aged | 1987 |
Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
Topics: Aged; Cardiotonic Agents; Clinical Trials as Topic; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Placebos; Random Allocation; Time Factors | 1987 |
Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors | 1988 |
[Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
Topics: Adult; Aged; Cardiotonic Agents; Dose-Response Relationship, Drug; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Statistics as Topic | 1988 |
MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response.
Topics: Arginine Vasopressin; Cardiotonic Agents; Clinical Trials as Topic; Enoximone; Female; Follow-Up Studies; Half-Life; Heart Failure; Hemodynamics; Humans; Imidazoles; Kinetics; Male; Middle Aged; Norepinephrine; Renin | 1985 |
MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Diarrhea; Digitalis Glycosides; Diuretics; Enoximone; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Middle Aged; Oxygen Consumption; Physical Exertion; Pulmonary Wedge Pressure; Rest; Stroke Volume; Vascular Resistance | 1985 |
100 other study(ies) available for enoximone and Cardiac Failure
Article | Year |
---|---|
Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for t
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiotonic Agents; Dogs; Female; Fibrinolytic Agents; Heart Failure; Humans; Imidazoles; Male; Myocardial Contraction; Platelet Aggregation; Pyridazines; Structure-Activity Relationship; Vasodilator Agents | 1989 |
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chemical Phenomena; Chemistry, Physical; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Pyridazines; Structure-Activity Relationship | 1985 |
Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure.
Topics: Animals; Cardiotonic Agents; Dogs; Guinea Pigs; Heart Failure; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines | 1984 |
Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Propanolamines; Retrospective Studies; Survival Rate; Ventilator Weaning | 2014 |
Oral Enoximone as an Alternative to Protracted Intravenous Medication in Severe Pediatric Myocardial Failure.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Child; Enoximone; Heart Failure; Hemodynamics; Humans; Milrinone; Ventricular Dysfunction, Left | 2016 |
Inotropic therapy for heart failure: paradise lost.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Humans | 2009 |
Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system.
Topics: Aged; Anesthesia; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Enoximone; Epinephrine; Female; Heart Failure; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Myocardial Infarction; Preoperative Care; Retrospective Studies; Risk Factors; Time Factors | 2002 |
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Dobutamine; Dopamine; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Enoximone; Epidemiologic Methods; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Nerve Tissue Proteins; Norepinephrine; Peptide Fragments; Prognosis; Shock, Cardiogenic | 2005 |
Rationale and design of the enoximone clinical trials program.
Topics: Administration, Oral; Cardiotonic Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Enoximone; Heart Failure; Hospitalization; Humans; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2005 |
Recovery of heart function in children with acute severe heart failure.
Topics: Acute Disease; Captopril; Carbazoles; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Databases, Factual; Digoxin; Enalapril; Enoximone; Female; Heart Failure; Heart Function Tests; Humans; Infant; Infant, Newborn; Male; Propanolamines; Treatment Outcome | 2008 |
Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance.
Topics: Adult; Cardiotonic Agents; Enoximone; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical; Vasodilation | 1984 |
Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure; Stroke Volume | 1984 |
Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
Topics: Adult; Aged; Cardiac Output; Cardiotonic Agents; Coronary Circulation; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Lactates; Male; Middle Aged; Myocardium; Oxygen Consumption; Pulmonary Wedge Pressure | 1984 |
Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Topics: Administration, Oral; Aged; Blood Pressure; Cardiotonic Agents; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Nausea; Pulmonary Wedge Pressure; Stroke Volume; Thrombocytopenia; Vascular Resistance | 1984 |
Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
Topics: Aged; Blood Pressure; Cardiac Volume; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Heart Failure; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Contraction; Pulmonary Wedge Pressure; Vascular Resistance; Vasodilator Agents | 1984 |
Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
Topics: Aged; Blood Flow Velocity; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Lactates; Lactic Acid; Male; Middle Aged; Myocardium; Oxygen Consumption | 1984 |
Quality of life in heart failure treated with enoximone.
Topics: Enoximone; Heart Failure; Humans; Quality of Life | 1995 |
Experience with the Berlin Heart Assist Device.
Topics: Adolescent; Adult; Age Factors; Berlin; Child; Decision Making; Enoximone; Female; Germany; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Risk Factors; Shock, Cardiogenic; Time Factors; Treatment Outcome | 1994 |
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
Topics: Aged; Cardiac Output, Low; Cohort Studies; Coronary Disease; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Vasodilation | 1994 |
[Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Dilated; Catecholamines; Coronary Disease; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume | 1994 |
Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Combined Modality Therapy; Dose-Response Relationship, Drug; Echocardiography; Enoximone; Epinephrine; Female; Heart Failure; Heart Transplantation; Hemodynamics; Hormones; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Renin; Stroke Volume | 1994 |
[Enoximone in the postoperative phase of heart surgery].
Topics: Aged; Cardiac Output, Low; Catecholamines; Coronary Artery Bypass; Drug Therapy, Combination; Electrocardiography; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Oxygen; Postoperative Complications; Pulmonary Gas Exchange; Stroke Volume; Vascular Resistance | 1994 |
Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Coronary Circulation; Drug Synergism; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption | 1993 |
Hemodynamic effects of prolonged enoximone infusion (7 days) in patients with severe chronic heart failure.
Topics: Aged; Cardiomyopathy, Dilated; Catecholamines; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Vascular Resistance | 1993 |
Enoximone therapy as pharmacological bridging to cardiac transplantation.
Topics: Adult; Electrocardiography, Ambulatory; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Preoperative Care | 1993 |
Pharmacological bridge to cardiac transplantation: current limitations.
Topics: Adult; Assisted Circulation; Cardiopulmonary Bypass; Cause of Death; Drug Administration Schedule; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Infusions, Intravenous; Male; Middle Aged; Resuscitation | 1993 |
Long-term outcome of enoximone therapy in patients with refractory heart failure.
Topics: Cardiomyopathy, Dilated; Cause of Death; Coronary Disease; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 1993 |
Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1993 |
Mechanism of action of OPC-8490 in human ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adult; Azetidines; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Ion Channels; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Quinolones; Sotalol; Ventricular Function; Veratridine | 1996 |
Successful treatment of heart failure with enoximone in a patient with cytochrome c oxidase deficiency.
Topics: Cytochrome-c Oxidase Deficiency; Enoximone; Female; Heart Failure; Humans; Infant; Phosphodiesterase Inhibitors | 1996 |
Phosphodiesterase inhibitors in refractory heart failure: bridge to beta-blockade?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Enoximone; Heart Failure; Humans; Metoprolol; Phosphodiesterase Inhibitors | 1998 |
High-dose enoximone to evaluate reversibility of pulmonary hypertension: is there a diagnostic value of neurohormonal measurements?
Topics: Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Cardiac Catheterization; Catecholamines; Endothelin-1; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Male; Middle Aged; Peptidyl-Dipeptidase A; Phosphodiesterase Inhibitors; Prognosis; Pulmonary Artery; Pulmonary Veins; Severity of Illness Index | 1999 |
Improved heart failure protection by FK664, a novel positive inotropic agent, in dog heart-lung preparations.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enoximone; Extracorporeal Circulation; Heart; Heart Failure; Imidazoles; Lung; Pyrimidinones | 1992 |
The influence of clinical intervention on pressure-volume relationships--the conductance (volume) technique.
Topics: Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiac Volume; Computer Graphics; Coronary Angiography; Coronary Disease; Enoximone; Heart Failure; Humans; Imidazoles; Myocardial Contraction; Myocardial Ischemia; Phosphodiesterase Inhibitors; Stroke Volume; Ventricular Function, Left | 1992 |
Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Catheterization, Swan-Ganz; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Edema | 1992 |
Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Topics: Adult; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Catecholamines; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Imidazoles; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Myocardium; Receptors, Adrenergic, beta; Survival Rate | 1991 |
[Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
Topics: Aldosterone; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Cardiotonic Agents; Enoximone; Epinephrine; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Neurotransmitter Agents; Norepinephrine; Renin | 1991 |
Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
Topics: Adult; Aged; Anaerobic Threshold; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Cardiotonic Agents; Electrocardiography, Ambulatory; Enoximone; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1991 |
Patterns of response to intravenous enoximone.
Topics: Aged; Cardiotonic Agents; Coronary Disease; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Monitoring, Physiologic | 1991 |
Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
Topics: Benzazepines; Cardiotonic Agents; Energy Metabolism; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Propanolamines; Vasodilator Agents; Xamoterol | 1991 |
Oral treatment with enoximone in patients referred for cardiac transplantation.
Topics: Administration, Oral; Cardiotonic Agents; Combined Modality Therapy; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Patient Discharge; Prognosis; Tachycardia | 1991 |
[Enoximone and cardiac insufficiency].
Topics: Enoximone; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1991 |
[Enoximone as pharmacologic "bridging" to heart transplantation].
Topics: Adolescent; Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Combined Modality Therapy; Coronary Disease; Enoximone; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Prognosis | 1991 |
[Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Topics: Cardiac Output; Cardiac Output, Low; Cardiomyopathy, Dilated; Cardiotonic Agents; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Myocardial Contraction; Phosphodiesterase Inhibitors | 1991 |
[Comparison of new cardiac agents using differential therapeutic criteria].
Topics: Adult; Aged; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications; Ventricular Function, Left | 1991 |
Enoximone and milrinone--inotropic vasodilators for severe heart failure.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Pyridones | 1991 |
Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
Topics: Cardiac Volume; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Radionuclide Angiography; Stroke Volume | 1991 |
Myocardial energetics in dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Enoximone; Heart; Heart Failure; Heart Rate; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Propanolamines; Pyridazines; Stroke Volume; Vascular Resistance; Vasodilator Agents; Xamoterol | 1990 |
The role of enoximone in cardiac failure. Proceedings of a satellite symposium to the XIth Congress of the European Society of Cardiology. Nice, France, 13 September 1989. Proceedings.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles | 1990 |
Differential hemodynamic effects of oral enoximone in severe congestive heart failure.
Topics: Administration, Oral; Cardiotonic Agents; Dose-Response Relationship, Drug; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1990 |
Lack of effect of enoximone on the pharmacokinetics of digoxin in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Digoxin; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged | 1990 |
Enoximone in chronic heart failure.
Topics: Cardiotonic Agents; Chronic Disease; Enoximone; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors; Survival Analysis | 1990 |
Enoximone improves selection of candidates for urgent cardiac transplantation.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Drug Evaluation; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies | 1990 |
Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiotonic Agents; Drug Therapy, Combination; Enoximone; Heart Failure; Heart Rate; Humans; Imidazoles; Infusions, Intravenous; Phosphodiesterase Inhibitors; Shock, Cardiogenic; Sympathomimetics | 1990 |
[Medical strategy in patients awaiting emergency heart transplantation].
Topics: Adult; Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Contraindications; Critical Care; Diuretics; Dobutamine; Dopamine; Emergencies; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Shock, Cardiogenic | 1990 |
[Enoximone in the treatment of acute cardiac insufficiency].
Topics: Acute Disease; Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles | 1990 |
[Enoximone in the treatment of acute heart failure. Paris, 9-10 March 1990. Proceedings].
Topics: Acute Disease; Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles | 1990 |
[Postoperative cardiac insufficiency. The value of enoximone].
Topics: Acute Disease; Anesthesia, General; Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles; Intraoperative Complications; Postoperative Complications; Risk Factors | 1990 |
Hemodynamic effects of prolonged intravenous therapy with enoximone in patients with severe congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Vascular Resistance | 1988 |
[Effect of oral long-term enoximone therapy on the arrhythmia profile in chronic heart failure].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiotonic Agents; Electrocardiography; Enoximone; Female; Heart Failure; Humans; Imidazoles; Long-Term Care; Male; Middle Aged; Monitoring, Physiologic; Retrospective Studies | 1988 |
Treatment of heart failure with enoximone, a new phosphodiesterase inhibitor. Düsseldorf, Federal Republic of Germany. September 25-27, 1987. Proceedings.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1989 |
Electrophysiologic effects of enoximone in patients with congestive heart failure.
Topics: Adult; Atrioventricular Node; Cardiotonic Agents; Electrocardiography; Electrophysiology; Enoximone; Female; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1989 |
The influence of various degrees of cardiac failure, chronic medical treatment, and acute additional enoximone application on the parameters of the vasopressor system.
Topics: Adult; Body Weight; Cardiomyopathy, Dilated; Cardiotonic Agents; Chromatography, High Pressure Liquid; Enoximone; Heart Failure; Hormones; Humans; Imidazoles; Injections, Intravenous; Middle Aged; Radioimmunoassay | 1989 |
Acute effects of enoximone in chronic heart failure.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1989 |
Chronic therapy of severe heart failure with enoximone.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged | 1989 |
Long-term enoximone therapy in unstable chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Electrocardiography; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1989 |
Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow.
Topics: Amrinone; Animals; Coronary Circulation; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones | 1989 |
The effects of enoximone on renal function in patients with congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiotonic Agents; Enoximone; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Imidazoles; Kidney; Male; Middle Aged; Plasma Volume; Renal Circulation | 1989 |
The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Pacing, Artificial; Cardiotonic Agents; Electrocardiography; Electrophysiology; Enoximone; Heart Conduction System; Heart Failure; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Stroke Volume | 1989 |
[Treatment of acute cardiovascular failure with a new inhibitor of phosphodiesterase III].
Topics: Enoximone; Female; Heart Failure; Humans; Imidazoles; Infant; Male; Middle Aged; Phosphodiesterase Inhibitors | 1989 |
Additive effects of enoximone and nitroprusside in unstable chronic heart failure.
Topics: Aged; Cardiotonic Agents; Drug Therapy, Combination; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside | 1989 |
Potentiation of the effects of enoximone by a dobutamine infusion.
Topics: Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Drug Synergism; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1989 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dogs; Dose-Response Relationship, Drug; Enoximone; Female; Heart Conduction System; Heart Failure; Heart Rate; Hemodynamics; Imidazoles; Male | 1985 |
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathies; Cardiomyopathy, Dilated; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged | 1986 |
Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
Topics: Aged; Arginine Vasopressin; Cardiotonic Agents; Depression, Chemical; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Norepinephrine; Renin; Stimulation, Chemical | 1986 |
Electrophysiological effects of intravenous MDL 17.043.
Topics: Adult; Aged; Atrioventricular Node; Cardiotonic Agents; Electrocardiography; Enoximone; Female; Heart Atria; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Sinoatrial Node | 1986 |
Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Dobutamine; Drug Evaluation; Enoximone; Heart Failure; Heart Rate; Humans; Imidazoles; Injections, Intravenous; Physical Exertion | 1986 |
Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
Topics: Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Enoximone; Ethanolamines; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Imidazoles | 1986 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside.
Topics: Diastole; Drug Evaluation; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Phosphodiesterase Inhibitors; Stroke Volume | 1987 |
Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
Topics: Blood Pressure; Blood Volume; Enoximone; Female; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Systole | 1987 |
Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Cardiotonic Agents; Death, Sudden; Drug Evaluation; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Milrinone; Pyridones; Quinazolines; Retrospective Studies; Time Factors | 1987 |
[Long-term therapy of chronic cardiac insufficiency using enoximone].
Topics: Adult; Cardiotonic Agents; Echocardiography; Enoximone; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Radiography | 1987 |
A symposium: The use of enoximone in heart failure. September 14, 1986, Washington, D.C. Proceedings.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles | 1987 |
Physiologic response to the inotropic and vasodilator properties of enoximone.
Topics: Animals; Cardiotonic Agents; Chronic Disease; Coronary Vessels; Dogs; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Models, Cardiovascular; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Oxygen Consumption; Vasodilation | 1987 |
Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metabolite.
Topics: Absorption; Administration, Oral; Animals; Biotransformation; Capsules; Cardiotonic Agents; Dogs; Enoximone; Female; Half-Life; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Kinetics; Male; Rats; Rats, Inbred Strains; Sulfoxides; Time Factors | 1987 |
Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.
Topics: Cardiotonic Agents; Coronary Vessels; Drug Evaluation; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardial Contraction; Stroke Volume; Vascular Resistance; Vasodilation | 1987 |
Long-term oral enoximone therapy in chronic cardiac failure.
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Chronic Disease; Drug Evaluation; Enoximone; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Long-Term Care; Male; Middle Aged | 1987 |
Effects of low dose enoximone for chronic congestive heart failure.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Chronic Disease; Drug Evaluation; Enoximone; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1987 |
Oral enoximone pharmacokinetics in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Proteins; Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles; Middle Aged; Protein Binding | 1987 |
The effects of enoximone (MDL-17043) on forearm venous circulation in healthy volunteers and patients with heart failure.
Topics: Adult; Aged; Blood Circulation; Cardiotonic Agents; Enoximone; Female; Forearm; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Veins | 1987 |
Effects of enoximone in patients with cardiac failure after myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors | 1988 |
Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.
Topics: Administration, Oral; Aged; Enoximone; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1985 |
Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Topics: Aged; Blood Pressure; Catecholamines; Dobutamine; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Pulmonary Artery; Stroke Volume; Vascular Resistance | 1985 |
Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Catecholamines; Coronary Circulation; Enoximone; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Myocardium; Oxygen Consumption; Vasodilator Agents | 1985 |
Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure.
Topics: Aged; Arginine Vasopressin; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Contrast Media; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Middle Aged; Osmolar Concentration; Osmotic Pressure; Water-Electrolyte Balance | 1985 |
Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Time Factors; Vasodilator Agents | 1985 |
Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failure.
Topics: Cardiotonic Agents; Chemical Phenomena; Chemistry; Enoximone; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Male; Myocardial Contraction; Vasodilation | 1985 |
Effects of amrinone on myocardial energetics in severe congestive heart failure.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Dogs; Enoximone; Heart; Heart Failure; Humans; Imidazoles; Isoproterenol; Milrinone; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones | 1985 |